340 related articles for article (PubMed ID: 29961654)
1. Stereotactic radiotherapy in three weekly fractions for the management of vestibular schwannomas.
Gallogly JA; Jumaily M; Faraji F; Mikulec AA
Am J Otolaryngol; 2018; 39(5):561-566. PubMed ID: 29961654
[TBL] [Abstract][Full Text] [Related]
2. [First experience of stereotactic radiation therapy for vestibular schwannoma using CyberKnife].
Zolotova SV; Golanov AV; Trunin IuIu; Galkin MV; Kotel'nikova TM; Antipina NA; Gorlachev GE; Nikonova NG; Pronin IN
Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(1):13-20; discussion 20. PubMed ID: 22629843
[TBL] [Abstract][Full Text] [Related]
3. Acoustic Neuroma Treated with Stereotactic Radiosurgery: Follow-up of 335 Patients.
Rueß D; Pöhlmann L; Hellerbach A; Hamisch C; Hoevels M; Treuer H; Grau S; Jablonska K; Kocher M; Ruge MI
World Neurosurg; 2018 Aug; 116():e194-e202. PubMed ID: 29715569
[TBL] [Abstract][Full Text] [Related]
4. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
5. Fractionated stereotactic radiosurgery for vestibular schwannomas using cyberknife: A single institution experience.
Kocak ME; Sengul A; Ekici K; Olmezoglu A; Seseogullari O
J Pak Med Assoc; 2016 Sep; 66(9):1089-1093. PubMed ID: 27654726
[TBL] [Abstract][Full Text] [Related]
6. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
[TBL] [Abstract][Full Text] [Related]
7. Staged stereotactic irradiation for acoustic neuroma.
Chang SD; Gibbs IC; Sakamoto GT; Lee E; Oyelese A; Adler JR
Neurosurgery; 2005 Jun; 56(6):1254-61; discussion 1261-3. PubMed ID: 15918941
[TBL] [Abstract][Full Text] [Related]
8. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma.
Morimoto M; Yoshioka Y; Kotsuma T; Adachi K; Shiomi H; Suzuki O; Seo Y; Koizumi M; Kagawa N; Kinoshita M; Hashimoto N; Ogawa K
Jpn J Clin Oncol; 2013 Aug; 43(8):805-12. PubMed ID: 23780990
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife
Puataweepong P; Dhanachai M; Swangsilpa T; Sitathanee C; Ruangkanchanasetr R; Hansasuta A; Pairat K
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e247-e254. PubMed ID: 34310064
[TBL] [Abstract][Full Text] [Related]
11. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
13. Effects of CyberKnife therapy for vestibular schwannoma on hearing: a retrospective study.
Çakır O; Berkiten G; Tutar B; Yılmazer AB; Kumral TL; Saltürk Z; Uyar Y
J Laryngol Otol; 2018 Sep; 132(9):796-801. PubMed ID: 30180915
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity.
Chan AW; Black P; Ojemann RG; Barker FG; Kooy HM; Lopes VV; McKenna MJ; Shrieve DC; Martuza RL; Loeffler JS
Neurosurgery; 2005 Jul; 57(1):60-70; discussion 60-70. PubMed ID: 15987541
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes and Dose Rate Effects Following Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannomas.
Smith DR; Saadatmand HJ; Wu CC; Black PJ; Wuu YR; Lesser J; Horan M; Isaacson SR; Wang TJC; Sisti MB
Neurosurgery; 2019 Dec; 85(6):E1084-E1094. PubMed ID: 31270543
[TBL] [Abstract][Full Text] [Related]
16. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
17. Multisession stereotactic radiosurgery for large vestibular schwannomas.
Casentini L; Fornezza U; Perini Z; Perissinotto E; Colombo F
J Neurosurg; 2015 Apr; 122(4):818-24. PubMed ID: 25594321
[TBL] [Abstract][Full Text] [Related]
18. Gamma Knife radiosurgery for vestibular schwannomas: evaluation of tumor control and its predictors in a large patient cohort in The Netherlands.
Klijn S; Verheul JB; Beute GN; Leenstra S; Mulder JJ; Kunst HP; Hanssens PE
J Neurosurg; 2016 Jun; 124(6):1619-26. PubMed ID: 26430848
[TBL] [Abstract][Full Text] [Related]
19. Local experience with radiosurgery for vestibular schwannomas and recommendations for management.
Wong RX; Low HYT; Tan DYH
Singapore Med J; 2018 Nov; 59(11):590-596. PubMed ID: 30182129
[TBL] [Abstract][Full Text] [Related]
20. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution.
Söderlund Diaz L; Hallqvist A
J Neurooncol; 2020 Apr; 147(2):351-359. PubMed ID: 32036575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
